Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Committee Leaders Want EHR Incentive Payments Paused Until Standards Are Strengthened

This article was originally published in The Pink Sheet Daily

Executive Summary

GOP leaders of the Energy & Commerce and Ways & Means committees ask CMS to halt incentive payments for meaningful use of electronic health records until true interoperable standards are developed and the criteria for demonstrating meaningful use are strengthened.

You may also be interested in...



OIG Raises Concerns About Accuracy Of Data In E-Health Records

A recent HHS Office of Inspector General report highlights problems with data entry in electronic health records, something that not only makes them vulnerable to fraud but also could compromise EHRs as a research tool.

GOP Senators Call For “Reboot” Of E-Health Records Incentive Program

Senators issue a white paper highlighting five areas that need to be addressed in order for electronic health records to meet the goals of better health outcomes, improved efficiency of health care delivery and lowering the overall cost of health care.

HHS Seeks Suggestions On Hastening E-Health Record Interoperability, Data Exchange

Hinting that the electronic health record incentive program is not resulting in quick-enough adoption of interoperable systems, HHS asks for suggestions on how to speed up the process of making EHRs interoperable, as well as to get providers to utilize health information exchange.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS073465

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel